Logo

Novavax Submits Final Data to Seek the US FDA’s EUA for its COVID-19 Vaccine

Share this

Novavax Submits Final Data to Seek the US FDA’s EUA for its COVID-19 Vaccine

Shots:

  • The company has submitted the chemistry, manufacturing and controls (CMC) data module, completing the final data packages required for the EUA application of NVX-CoV2373 with Matrix-M adjuvant
  • Novavax is all set to file an application with the US FDA in 30 days, seeking EUA for its vaccine, as per the FDA guidance for all EUA applications for vaccines
  • The company plans to later supplement the submission, with data from additional manufacturing sites across its global supply chain

Ref: Novavax | Image: Medpage Today

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions